Niva Bupa Health Insurance Company Limited (BOM:544286)
86.51
+0.76 (0.89%)
At close: Jul 10, 2026
BOM:544286 Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, BOM:544286 stock has a consensus rating of "Buy" and an average price target of ₹93.36. The average 1-year stock price forecast is 7.92% higher than the current stock price, while the lowest is ₹85.00 (-1.75%) and the highest is ₹105.00 (+21.37%).
Price Target: ₹93.36 (+7.92%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BOM:544286 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Financial Forecast
Revenue This Year
90.47B
from 84.43B
Increased by 7.15%
Revenue Next Year
111.50B
from 90.47B
Increased by 23.24%
EPS This Year
1.71
from 0.71
Increased by 140.97%
EPS Next Year
2.65
from 1.71
Increased by 54.99%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 99.0B | ||
| Avg | 90.5B | ||
| Low | 82.2B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 17.3% | ||
| Avg | 7.1% | ||
| Low | -2.7% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 3.00 | ||
| Avg | 1.71 | ||
| Low | 0.90 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 322.5% | ||
| Avg | 141.0% | ||
| Low | 26.8% |